Related Experiment Video
Updated: Sep 25, 2025

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins
Published on: October 18, 2022
[Prevention and control of antimicrobial resistance using CRISPR-Cas system: a review]
Chenyu Wang1, Zhizhi Liu1, Biao Tang2
1College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, China.
Abstract:
Bacterial multi-drug resistance (MDR) is a global challenge in the fields of medicine and health, agriculture and fishery, ecology and environment. The cross-region spread of antibiotic resistance genes (ARGs) among different species is one of the main cause of bacterial MDR. However, there is no effective strategies for addressing the intensifying bacterial MDR. The CRISPR-Cas system, consisting of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR associated proteins, can targetedly degrade exogenous nucleic acids, thus exhibiting high application potential in preventing and controlling bacterial MDR caused by ARGs. This review briefly introduced the working mechanism of CRISPR-Cas systems, followed by discussing recent advances in reducing ARGs by CRISPR-Cas systems delivered through mediators (e.g. plasmids, bacteriophages and nanoparticle). Moreover, the trends of this research field were envisioned, providing a new perspective on preventing and controlling MDR.
Insights
CRISPR-Cas systems offer a novel approach to combat bacterial multi-drug resistance (MDR) by targeting antibiotic resistance genes (ARGs). This technology shows promise for controlling MDR across various sectors.
Area of Science:
- Microbiology
- Molecular Biology
- Biotechnology
Background:
- Bacterial multi-drug resistance (MDR) poses a significant global threat across medicine, agriculture, and environmental sectors.
- The spread of antibiotic resistance genes (ARGs) is a primary driver of increasing bacterial MDR.
- Current strategies for combating bacterial MDR are insufficient to address the escalating challenge.
Purpose of the Study:
- To review the mechanism of CRISPR-Cas systems.
- To discuss recent advancements in utilizing CRISPR-Cas systems for reducing ARGs.
- To explore the potential of CRISPR-Cas systems in preventing and controlling bacterial MDR.
Main Methods:
- Review of the CRISPR-Cas system's working mechanism.
- Analysis of recent studies on CRISPR-Cas mediated ARG reduction.
- Discussion of delivery methods for CRISPR-Cas systems, including plasmids, bacteriophages, and nanoparticles.
Main Results:
- CRISPR-Cas systems can be engineered to target and degrade specific ARGs.
- Various delivery systems are being explored to enhance the efficiency of CRISPR-Cas based ARG reduction.
- CRISPR-Cas technology demonstrates significant potential for controlling MDR.
Conclusions:
- CRISPR-Cas systems represent a promising innovative strategy for combating bacterial MDR.
- Further research and development in CRISPR-Cas delivery methods are crucial for practical applications.
- This technology offers a new perspective for preventing and controlling the spread of ARGs and MDR.
More Related Videos
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The Antiviral System of Bacteria and Archaea: CRISPR
CRISPR
Homologous Recombination

